1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

EcoR1 Capital, LLC Buys Arvinas Inc, Assembly Biosciences Inc, Morphic Holding Inc, Sells Spark Therapeutics Inc, argenx SE, Solid Biosciences Inc

San Francisco, CA, based Investment company EcoR1 Capital, LLC (Current Portfolio) buys Arvinas Inc, Assembly Biosciences Inc, Morphic Holding Inc, AnaptysBio Inc, Innate Pharma SA, sells Spark Therapeutics Inc, argenx SE, Solid Biosciences Inc, Sarepta Therapeutics Inc, NextCure Inc during the 3-months ended 2019Q4, according to the most recent filings of the investment company, EcoR1 Capital, LLC. As of 2019Q4, EcoR1 Capital, LLC owns 41 stocks with a total value of $1.1 billion. These are the details of the buys and sells.

For the details of EcoR1 Capital, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/ecor1+capital%2C+llc/current-portfolio/portfolio

These are the top 5 holdings of EcoR1 Capital, LLC
  1. Prothena Corp PLC (PRTA) - 9,426,640 shares, 13.83% of the total portfolio.
  2. Xencor Inc (XNCR) - 2,501,557 shares, 7.97% of the total portfolio.
  3. Dicerna Pharmaceuticals Inc (DRNA) - 3,627,597 shares, 7.40% of the total portfolio. Shares reduced by 8.46%
  4. FibroGen Inc (FGEN) - 1,492,221 shares, 5.93% of the total portfolio. Shares added by 15.34%
  5. Kura Oncology Inc (KURA) - 4,241,953 shares, 5.40% of the total portfolio. Shares added by 4.95%
New Purchase: Arvinas Inc (ARVN)

EcoR1 Capital, LLC initiated holding in Arvinas Inc. The purchase prices were between $15.39 and $44.38, with an estimated average price of $29.74. The stock is now traded at around $49.92. The impact to a portfolio due to this purchase was 5.1%. The holding were 1,339,069 shares as of .

New Purchase: Morphic Holding Inc (MORF)

EcoR1 Capital, LLC initiated holding in Morphic Holding Inc. The purchase prices were between $13.02 and $19.5, with an estimated average price of $15.61. The stock is now traded at around $15.42. The impact to a portfolio due to this purchase was 3.43%. The holding were 2,154,845 shares as of .

New Purchase: AnaptysBio Inc (ANAB)

EcoR1 Capital, LLC initiated holding in AnaptysBio Inc. The purchase prices were between $10.18 and $38.96, with an estimated average price of $23.27. The stock is now traded at around $15.77. The impact to a portfolio due to this purchase was 2.96%. The holding were 1,966,100 shares as of .

New Purchase: Innate Pharma SA (IDDA)

EcoR1 Capital, LLC initiated holding in Innate Pharma SA. The purchase prices were between $4.84 and $5.7, with an estimated average price of $5.32. The stock is now traded at around $6.50. The impact to a portfolio due to this purchase was 2.71%. The holding were 4,545,454 shares as of .

New Purchase: ACADIA Pharmaceuticals Inc (ACAD)

EcoR1 Capital, LLC initiated holding in ACADIA Pharmaceuticals Inc. The purchase prices were between $37.4 and $51.4, with an estimated average price of $43.7. The stock is now traded at around $45.44. The impact to a portfolio due to this purchase was 1.98%. The holding were 500,000 shares as of .

New Purchase: Sage Therapeutics Inc (SAGE)

EcoR1 Capital, LLC initiated holding in Sage Therapeutics Inc. The purchase prices were between $60.18 and $154.77, with an estimated average price of $122.53. The stock is now traded at around $68.61. The impact to a portfolio due to this purchase was 1.16%. The holding were 173,364 shares as of .

Added: Assembly Biosciences Inc (ASMB)

EcoR1 Capital, LLC added to a holding in Assembly Biosciences Inc by 2372.33%. The purchase prices were between $8.36 and $23.81, with an estimated average price of $15.55. The stock is now traded at around $20.95. The impact to a portfolio due to this purchase was 4.35%. The holding were 2,388,268 shares as of .

Added: Merus NV (MRUS)

EcoR1 Capital, LLC added to a holding in Merus NV by 937.56%. The purchase prices were between $14.08 and $18.5, with an estimated average price of $16.06. The stock is now traded at around $19.15. The impact to a portfolio due to this purchase was 2.02%. The holding were 1,718,200 shares as of .

Added: Neoleukin Therapeutics Inc (NLTX)

EcoR1 Capital, LLC added to a holding in Neoleukin Therapeutics Inc by 72.82%. The purchase prices were between $2.65 and $12.72, with an estimated average price of $5.14. The stock is now traded at around $11.11. The impact to a portfolio due to this purchase was 1.88%. The holding were 3,915,880 shares as of .

Added: Ultragenyx Pharmaceutical Inc (RARE)

EcoR1 Capital, LLC added to a holding in Ultragenyx Pharmaceutical Inc by 324.92%. The purchase prices were between $36.08 and $45.83, with an estimated average price of $41.28. The stock is now traded at around $61.10. The impact to a portfolio due to this purchase was 0.8%. The holding were 261,554 shares as of .

Added: Cyclerion Therapeutics Inc (CYCN)

EcoR1 Capital, LLC added to a holding in Cyclerion Therapeutics Inc by 133.31%. The purchase prices were between $1.8 and $13.43, with an estimated average price of $4.51. The stock is now traded at around $4.04. The impact to a portfolio due to this purchase was 0.26%. The holding were 1,811,000 shares as of .

Added: Mirati Therapeutics Inc (MRTX)

EcoR1 Capital, LLC added to a holding in Mirati Therapeutics Inc by 46.99%. The purchase prices were between $70.76 and $128.86, with an estimated average price of $97.36. The stock is now traded at around $96.72. The impact to a portfolio due to this purchase was 0.25%. The holding were 65,000 shares as of .

Sold Out: Spark Therapeutics Inc (ONCE)

EcoR1 Capital, LLC sold out a holding in Spark Therapeutics Inc. The sale prices were between $96.25 and $113.57, with an estimated average price of $107.51.

Sold Out: Solid Biosciences Inc (SLDB)

EcoR1 Capital, LLC sold out a holding in Solid Biosciences Inc. The sale prices were between $2.82 and $12.9, with an estimated average price of $7.22.

Sold Out: Sarepta Therapeutics Inc (SRPT)

EcoR1 Capital, LLC sold out a holding in Sarepta Therapeutics Inc. The sale prices were between $77.69 and $135.58, with an estimated average price of $101.97.

Sold Out: NextCure Inc (NXTC)

EcoR1 Capital, LLC sold out a holding in NextCure Inc. The sale prices were between $25 and $92.22, with an estimated average price of $42.28.

Sold Out: Curis Inc (CRIS)

EcoR1 Capital, LLC sold out a holding in Curis Inc. The sale prices were between $1.36 and $2.44, with an estimated average price of $1.81.

Sold Out: Zafgen Inc (ZFGN)

EcoR1 Capital, LLC sold out a holding in Zafgen Inc. The sale prices were between $0.7 and $1.25, with an estimated average price of $0.8.



Here is the complete portfolio of EcoR1 Capital, LLC. Also check out:

1. EcoR1 Capital, LLC's Undervalued Stocks
2. EcoR1 Capital, LLC's Top Growth Companies, and
3. EcoR1 Capital, LLC's High Yield stocks
4. Stocks that EcoR1 Capital, LLC keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)